Welcome to Ozempic town USA: Wealthy mountainous city where everyone’s abusing the drugs and private school moms have been turned into ‘skeletons’
The Daily Mail reports on Denver, Colorado, which it describes as a hotspot for weight-loss drug use, claiming Ozempic and similar GLP-1 medications have become so widespread among wealthy residents that some women, including private-school mothers, have become dangerously thin. The article frames the city's affluent, health-conscious culture as fuelling excessive reliance on the drugs, raising concerns about misuse beyond their intended medical purpose and the emergence of a black market for obtaining them.
The piece links Denver's mountainous, fitness-focused lifestyle and wealth to a surge in demand for weight-loss injections, suggesting the drugs are being used for cosmetic weight loss rather than managing diabetes or obesity as originally intended. It also touches on concerns about unregulated or black-market access to the medications, though the article provides limited concrete data or medical sourcing to substantiate the scale of the described "abuse".
- Denver dubbed "Ozempic town" over widespread weight-loss drug use
- Wealthy residents, including private-school mothers, reportedly using drugs excessively
- Article raises concerns over black-market access to the medications
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Advocates for wider, including cosmetic or lifestyle, use of GLP-1 drugs argue that adults are entitled to make informed choices about their own bodies and health with a doctor's oversight, and that these medications have shown real benefits beyond diabetes management, including improved cardiovascular markers and quality of life. They contend that stigmatising users, particularly women in affluent communities, reflects outdated moralising about weight loss rather than genuine medical concern, and that if a treatment is legally prescribed and monitored, it is not the media's or public's place to police who takes it or why. They also note that normalising these drugs may reduce the shame historically attached to obesity treatment.
The case against
Critics worry that widespread elective use among already slim, wealthy residents signals a troubling cultural shift towards extreme thinness as an aspirational norm, particularly in communities with children and teenagers watching closely. They point to documented supply shortages that have made it harder for diabetic patients who medically depend on these drugs to access them, arguing that cosmetic demand from the affluent is crowding out genuine medical need. There is also concern that visible, dramatic weight loss among mothers in tight-knit social circles can fuel disordered eating and body dysmorphia, especially among impressionable young people, and that this warrants closer scrutiny rather than uncritical acceptance.